Male Pattern Baldness

Hair Transplant Blog RSS FeedHair Transplant Blog Via EmailHair Transplant Blog Homepage

What Is The Status Of The Latisse For Hair Loss Study?

May 18th, 2011

Q: I saw your post on the clinical trials of Latisse (bimatoprost) for hair loss on the scalp. What is the status of the study?

A: Allergan, the company that makes Latisse, is conducting safety and efficacy testing of three formulations of the drug for men with androgenetic alopecia (male pattern baldness). The first phase of the trials is now complete and the study has moved into phase II. In this phase, the pharmaceutical company will be studying the results of the same three formulations of the drug, but this time they will be comparing them to results of a control option and also an over-the-counter minoxidil 5% solution.




Rating: 1 Star2 Stars3 Stars4 Stars5 Stars  

Topic:

Tags: , , , , , ,
Posted by Robert M. Bernstein M.D. at 6:10 pm

Hair Cloning “Just A Question Of Time” Dr. Bernstein Tells New York Times

May 5th, 2011

NYT - New Stratagems in the Quest for HairDr. Bernstein is featured in a New York Times article — “New Stratagems in the Quest for Hair” — about the latest advances in hair restoration. The article mentions Dr. Bernstein’s pioneering research on hair cloning, including his studies on hair multiplication using the breakthrough biotechnology of ACell’s MatriStem® extracellular matrix.




Rating: 1 Star2 Stars3 Stars4 Stars5 Stars   4.20 stars from 5 vote(s)

Topic:

Tags: , , , , , , , , , , ,
Posted by Ethan at Bernstein Medical at 11:43 am

Is Genetic Hair Loss Linked to Other Diseases?

March 9th, 2011

Q: There was a retrospective study by Lotufo et al. linking male pattern baldness to heart disease. Do you think there are other links like this for androgenetic alopecia?

A: Family studies revealed both the androgen receptor locus on the X chromosome, as well as a new locus on chromosome 3q26. Association studies performed in two independent groups revealed a locus on chromosome 20 (not near any known genes) as well as the androgen receptor on the X chromosome. Read on for the rest of the answer.




Rating: 1 Star2 Stars3 Stars4 Stars5 Stars  

Topic:

Tags: , , , , , , , , , , ,
Posted by Robert M. Bernstein M.D. at 3:00 pm

Research Points to Decreased “Progenitor” Stem Cells as Cause of Male Pattern Baldness

January 7th, 2011

Research published in the January 2011 issue of the Journal of Clinical Investigation (Vol. 121, issue 1) reveals another breakthrough in the medical community’s understanding of the causes of — and possible cure for — androgenetic alopecia, or common male pattern baldness. The new research shows that the presence of a certain type of cell, called a progenitor cell, is significantly reduced in men with common baldness compared to men who are not bald. Read on for more details on this breakthrough.




Rating: 1 Star2 Stars3 Stars4 Stars5 Stars   5.00 stars from 3 vote(s)

Topic:

Tags: , , , , , , , , , ,
Posted by Ethan at Bernstein Medical at 3:33 pm

Latisse Drug as Hair Loss Treatment? Trials Under Way on New Formulation of Bimatoprost

January 6th, 2011

Latisse, the brand name for the drug bimatoprost, is commonly used to promote eyelash growth in women who want their eyelashes to be longer, thicker, and darker, typically for cosmetic reasons.

In a publication on ClinicalTrials.gov, Allergan, the pharmaceutical company that produces Latisse, has announced a new study on the safety and efficacy of a new formulation of bimatoprost for use as a topical hair loss treatment for general baldness.




Rating: 1 Star2 Stars3 Stars4 Stars5 Stars   4.50 stars from 2 vote(s)

Topic:

Tags: , , , , , , , , ,
Posted by Ethan at Bernstein Medical at 11:02 am






▲ Top of Page



© 2005-2012 Bernstein Medical, P.C. All Rights Reserved.